|
|
||||||||
RESEARCH COMMUNICATION |
a Laboratoire de Biologie Moléculaire Eucaryote du CNRS, 31062 Toulouse, France
b LIIPAT, Institute of Pathology, University of Oslo, Rikshospitalet, Oslo, Norway
High endothelial venules (HEVs) are specialized postcapillary venules found in lymphoid organs and chronically inflamed tissues that support high levels of lymphocyte extravasation from the blood. Studies with chlorate, a metabolic inhibitor of sulfation, had previously revealed that production of PAPS (3'-phosphoadenosine-5'-phosphosulfate), the high-energy donor of sulfate, is required for sulfation and high-affinity recognition of HEV sialomucins GlyCAM-1 and CD34 by the lymphocyte homing receptor L-selectin. Here, we report the molecular characterization of a novel 2.5 kb human cDNA from MECA-79+ HEV-derived endothelial cells that encodes the target of chlorate, PAPS synthetase, a multifunctional enzyme containing domains for both ATP sulfurylase and adenosine-5'-phosphosulfate kinase. Functional expression of the isolated cDNA in Chinese hamster ovary cells results in high levels of PAPS synthesis, which is abolished by treatment of the transfected cells with chlorate. Northern blot analysis reveals a wide tissue distribution of PAPS synthetase mRNA in the human body, suggesting that human PAPS synthetase may be important for sulfation not only of HEV sialomucins, but also of many other molecules, including mucins such as the P-selectin ligand PSGL-1, proteoglycans, hormones, neurotransmitters, drugs, and xenobiotics.Girard, J.-P., Baekkevold, E. S., Amalric, F. Sulfation in high endothelial venules: cloning and expression of the human PAPS synthetase. FASEB J. 12, 603612 (1998)
Key Words: ATP sulfurylase APS kinase endothelium lymphocyte recirculation
This article has been cited by other articles:
![]() |
G. Dick, F. Grondahl, and K. Prydz Overexpression of the 3'-Phosphoadenosine 5'-Phosphosulfate (PAPS) Transporter 1 Increases Sulfation of Chondroitin Sulfate in the Apical Pathway of MDCK II Cells Glycobiology, January 1, 2008; 18(1): 53 - 65. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Alnouti and C. D. Klaassen Tissue Distribution and Ontogeny of Sulfotransferase Enzymes in Mice Toxicol. Sci., October 1, 2006; 93(2): 242 - 255. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kamiyama, N. Sasaki, E. Goda, K. Ui-Tei, K. Saigo, H. Narimatsu, Y. Jigami, R. Kannagi, T. Irimura, and S. Nishihara Molecular Cloning and Characterization of a Novel 3'-Phosphoadenosine 5'-Phosphosulfate Transporter, PAPST2 J. Biol. Chem., April 21, 2006; 281(16): 10945 - 10953. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Dejima, A. Seko, K. Yamashita, K. Gengyo-Ando, S. Mitani, T. Izumikawa, H. Kitagawa, K. Sugahara, S. Mizuguchi, and K. Nomura Essential Roles of 3'-Phosphoadenosine 5'-Phoshosulfate Synthase in Embryonic and Larval Development of the Nematode Caenorhabditis elegans J. Biol. Chem., April 21, 2006; 281(16): 11431 - 11440. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. D. Spiegelberg, J. dela Cruz, T.-H. Law, and J. D. York Alteration of Lithium Pharmacology through Manipulation of Phosphoadenosine Phosphate Metabolism J. Biol. Chem., February 18, 2005; 280(7): 5400 - 5405. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Strott Sulfonation and Molecular Action Endocr. Rev., October 1, 2002; 23(5): 703 - 732. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-H. Xu, T. C. Wood, A. A. Adjei, and R. M. Weinshilboum Human 3'-Phosphoadenosine 5'-Phosphosulfate Synthetase: Radiochemical Enzymatic Assay, Biochemical Properties, and Hepatic Variation Drug Metab. Dispos., February 1, 2001; 29(2): 172 - 178. [Abstract] [Full Text] |
||||
![]() |
S. Hemmerich and S. D. Rosen MINI REVIEW Carbohydrate sulfotransferases in lymphocyte homing Glycobiology, September 1, 2000; 10(9): 849 - 856. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Watt, L. H. Butler, M. Tavian, H.-J. Buhring, I. Rappold, P. J. Simmons, A. C. W. Zannettino, D. Buck, A. Fuchs, R. Doyonnas, et al. Functionally defined CD164 epitopes are expressed on CD34+ cells throughout ontogeny but display distinct distribution patterns in adult hematopoietic and nonhematopoietic tissues Blood, May 15, 2000; 95(10): 3113 - 3124. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. BESSET, J.-B. VINCOURT, F. AMALRIC, and J.-P. GIRARD Nuclear localization of PAPS synthetase 1: a sulfate activation pathway in the nucleus of eukaryotic cells FASEB J, February 1, 2000; 14(2): 345 - 354. [Abstract] [Full Text] |
||||
![]() |
F. Safaiyan, S. O. Kolset, K. Prydz, E. Gottfridsson, U. Lindahl, and M. Salmivirta Selective Effects of Sodium Chlorate Treatment on the Sulfation of Heparan Sulfate J. Biol. Chem., December 17, 1999; 274(51): 36267 - 36273. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-P. Girard, E. S. Baekkevold, T. Yamanaka, G. Haraldsen, P. Brandtzaeg, and F. Amalric Heterogeneity of Endothelial Cells : The Specialized Phenotype of Human High Endothelial VenulesCharacterized by Suppression Subtractive Hybridization Am. J. Pathol., December 1, 1999; 155(6): 2043 - 2055. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-P. Girard, E. S. Baekkevold, J. Feliu, P. Brandtzaeg, and F. Amalric Molecular cloning and functional analysis of SUT-1, a sulfate transporter from human high endothelial venules PNAS, October 26, 1999; 96(22): 12772 - 12777. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Rosen Endothelial Ligands for L-Selectin : From Lymphocyte Recirculation to Allograft Rejection Am. J. Pathol., October 1, 1999; 155(4): 1013 - 1020. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |